CIK 0001434647
- Non-accelerated filer
- Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205894398
- Phone
- +1 888-958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-08-17 | Mickle Christal M M VP Prod Dev | Purchase | +5,000 | $4.95 | $25K | 7,050 |
| 2016-08-17 | Mickle Travis C President & CEO | Purchase | +5,000 | $4.95 | $25K | 7,050 |
| 2016-05-24 | Tierney David S Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Thompson Danny L Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Saluri Joseph Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Plooster Matthew R Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2016-05-24 | Pascoe Richard W Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2016-04-04 | Thompson Danny L Director | Exercise or conversion | +13,333 | $4.65 | $62K | 13,333 |
| 2016-04-04 | Thompson Danny L Director | Exercise or conversion · Stock Option (right to buy) | −13,333 | 0 | ||
| 2016-03-29 | Mickle Christal M M VP Prod Dev | Purchase | +400 | $14.49 | $6K | 33,614 |
| 2016-03-29 | Mickle Christal M M VP Prod Dev | Purchase | +2,050 | $14.59 | $30K | 2,050 |
| 2016-03-29 | Mickle Travis C President & CEO | Purchase | +2,050 | $14.59 | $30K | 2,050 |
| 2016-03-29 | Mickle Travis C President & CEO | Purchase | +400 | $14.49 | $6K | 33,614 |
| 2016-02-11 | Clifton R. LaDuane Chief Financial Officer & Sec | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Guenther Sven Exec VP R&D | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Woody Tracy M Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Johnson Gordon K Chief Business Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2016-02-11 | Mickle Christal M M VP Prod Dev | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2016-02-11 | Mickle Christal M M VP Prod Dev | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2016-02-11 | Mickle Travis C President & CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 |
Page 21 of 25 · 499 trades